vimarsana.com

Page 4 - வளரும் நாடுகள் மருத்துவ சோதனைகள் கூட்டு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Largest clinical trial in Africa for people with mild COVID-19 to test new treatment

Largest clinical trial in Africa for people with mild COVID-19 to test new treatment
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

The Covid tool every nation still needs

POLITICO Get the POLITICO Global Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. 04/22/2021 10:00 AM EDT This week we re looking at the status of Covid-19 treatments while the world waits for more vaccines. THE BIG IDEA SIENA, ITALY - FEBRUARY 22: Researchers work in Monoclonal Antibody Discovery Lab at TLS Foundation on February 22, 2021 in Siena, Italy. | Gianluca Panella/Getty Images

Intensify Hepatitis B vaccination awareness- Noguchi director urges govt

705 The Director of the Noguchi Memorial Institute for Medical Research (NMIMR) of the University of Ghana, Professor Abraham Kwabena Annan, has called on the government to intensify the coverage of hepatitis B vaccination in the country as part of measures to keep the viral disease at bay. He said although the country had made significant strides in the fight against the disease, including the adoption of a national guideline for the prevention, care and treatment of viral hepatitis, issues of low education, awareness and vaccination remained a major challenge. He called on the government to build partnerships with health professionals, institutions and stakeholders to implement a vaccination plan that would help intensify coverage and precisely target vulnerable groups and communities.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.